Timolol 0.5% versus Latanoprost 0.005% as A Single Hypotensive Drug in Glaucoma Patients: A 2-year Follow-up

Background: Glaucoma is a progressive optic nerve disease that, despite its treatment, is associated with retinal ganglion cell damage. However, timely treatment hinders the progression of visual field damage and preserves visual function. Our study aimed to evaluate the treatment outcomes and adver...

Full description

Bibliographic Details
Published in:International Journal of Biomedicine
Main Authors: Gentian Hoxha, Flaka Shoshi, Fëllanza Ismajli Hoxha, Agim Xhafa, Fitore Shoshi
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2024-12-01
Subjects:
Online Access:http://www.ijbm.org/articles/i56/ijbm_14(4)_oa15.pdf